These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 39238705)

  • 1. Cardio-Oncology's Modern Approaches to Prevent Doxorubicin-Induced Cardiotoxicity: A Systematic Review.
    Palvia AR; Damera AR; Nandi AR; Magar S; Patidar S; Kasarla S; Ghantasala V; Shah MK; Goyal M
    Cureus; 2024 Aug; 16(8):e66215. PubMed ID: 39238705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visnagin: A novel cardioprotective agent against anthracycline toxicity (Review).
    Obeidat O; Obeidat A; Obeidat A; Ismail MF
    Med Int (Lond); 2024; 4(4):37. PubMed ID: 38799005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research progress on the role and mechanism of Sirtuin family in doxorubicin cardiotoxicity.
    Zhang X; Huang C; Hou Y; Jiang S; Zhang Y; Wang S; Chen J; Lai J; Wu L; Duan H; He S; Liu X; Yu S; Cai Y
    Phytomedicine; 2024 Jul; 129():155673. PubMed ID: 38677274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
    Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
    Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for preventing anthracycline-induced clinical and subclinical cardiotoxicity: A network meta-analysis of metastatic breast cancer.
    Ghasemi K; Vaseghi G; Mansourian M
    J Oncol Pharm Pract; 2021 Mar; 27(2):414-427. PubMed ID: 33081570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
    Upadhyay S; Mantha AK; Dhiman M
    J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of
    Dallons M; Schepkens C; Dupuis A; Tagliatti V; Colet JM
    Front Pharmacol; 2020; 11():79. PubMed ID: 32153402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
    Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
    Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
    Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.
    Jain A; Rani V
    Mol Cell Biochem; 2018 May; 442(1-2):81-96. PubMed ID: 28929270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT
    Huang CY; Chen JY; Kuo CH; Pai PY; Ho TJ; Chen TS; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jan; 233(1):463-475. PubMed ID: 28295305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Lipoic Acid Protects Against Doxorubicin-Induced Cardiotoxicity by Regulating Pyruvate Dehydrogenase Kinase 4.
    Gong F; Jin J; Li H; Mao H
    Cardiovasc Toxicol; 2022 Nov; 22(10-11):879-891. PubMed ID: 35930219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
    Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
    Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity.
    Liu H; Wang H; Xiang D; Guo W
    Mini Rev Med Chem; 2017; 17(1):44-50. PubMed ID: 27337969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of
    Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
    Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
    Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
    J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine alleviates doxorubicin cardiotoxicity by inhibiting mitochondrial reactive oxygen species generation.
    Yu JL; Jin Y; Cao XY; Gu HH
    Hum Cell; 2020 Jan; 33(1):47-56. PubMed ID: 31643023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.